Chemours annual return on equity
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Chemours Return on Equity (ROE) Growth & History (CC)
Chemours's return on equity was −94.03% for fiscal 2025.
View full Chemours company overviewChemours annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −94.03% | −104.71 pp |
| 2024 | 2024-12-31 | 10.68% | +38.36 pp |
| 2023 | 2023-12-31 | −27.68% | −80.51 pp |
| 2022 | 2022-12-31 | 52.83% | −11.37 pp |
| 2021 | 2021-12-31 | 64.20% | +35.04 pp |
| 2020 | 2020-12-31 | 29.16% | +35.27 pp |
| 2019 | 2019-12-31 | −6.11% | −112.30 pp |
| 2018 | 2018-12-31 | 106.19% | −49.23 pp |
| 2017 | 2017-12-31 | 155.42% | +149.22 pp |
| 2016 | 2016-12-31 | 6.19% | +10.94 pp |
| 2015 | 2015-12-31 | −4.74% | −16.36 pp |
| 2014 | 2014-12-31 | 11.62% | — |
Chemours quarterly return on equity
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −330.12% | −234.40 pp |
| Q1 2026 | 2026-03-31 | −12.47% | −11.59 pp |
| Q4 2025 | 2025-12-31 | −17.94% | −16.13 pp |
| Q3 2025 | 2025-09-30 | 18.33% | +23.04 pp |
| Q2 2025 | 2025-06-30 | −95.72% | −103.90 pp |
| Q1 2025 | 2025-03-31 | −0.88% | −8.21 pp |
| Q4 2024 | 2024-12-31 | −1.81% | +0.63 pp |
| Q3 2024 | 2024-09-30 | −4.72% | −6.25 pp |
| Q2 2024 | 2024-06-30 | 8.18% | +45.13 pp |
| Q1 2024 | 2024-03-31 | 7.33% | −5.10 pp |
| Q4 2023 | 2023-12-31 | −2.44% | +5.67 pp |
| Q3 2023 | 2023-09-30 | 1.54% | −17.68 pp |
| Q2 2023 | 2023-06-30 | −36.95% | −53.84 pp |
| Q1 2023 | 2023-03-31 | 12.43% | −8.40 pp |
| Q4 2022 | 2022-12-31 | −8.11% | −30.43 pp |
| Q3 2022 | 2022-09-30 | 19.22% | −3.36 pp |
| Q2 2022 | 2022-06-30 | 16.89% | +9.34 pp |
| Q1 2022 | 2022-03-31 | 20.83% | +9.28 pp |
| Q4 2021 | 2021-12-31 | 22.32% | +19.86 pp |
| Q3 2021 | 2021-09-30 | 22.57% | +11.63 pp |
| Q2 2021 | 2021-06-30 | 7.55% | +3.89 pp |
| Q1 2021 | 2021-03-31 | 11.55% | −3.34 pp |
| Q4 2020 | 2020-12-31 | 2.46% | +44.01 pp |
| Q3 2020 | 2020-09-30 | 10.94% | +1.79 pp |
| Q2 2020 | 2020-06-30 | 3.66% | −8.10 pp |
| Q1 2020 | 2020-03-31 | 14.88% | +4.57 pp |
| Q4 2019 | 2019-12-31 | −41.55% | −54.73 pp |
| Q3 2019 | 2019-09-30 | 9.16% | −16.32 pp |
| Q2 2019 | 2019-06-30 | 11.76% | −16.12 pp |
| Q1 2019 | 2019-03-31 | 10.31% | −21.68 pp |
| Q4 2018 | 2018-12-31 | 13.18% | −14.29 pp |
| Q3 2018 | 2018-09-30 | 25.47% | −4.81 pp |
| Q2 2018 | 2018-06-30 | 27.88% | −7.12 pp |
| Q1 2018 | 2018-03-31 | 31.99% | −34.24 pp |
| Q4 2017 | 2017-12-31 | 27.47% | +123.91 pp |
| Q3 2017 | 2017-09-30 | 30.29% | −44.99 pp |
| Q2 2017 | 2017-06-30 | 35.00% | +45.20 pp |
| Q1 2017 | 2017-03-31 | 66.23% | +33.74 pp |
| Q4 2016 | 2016-12-31 | −96.44% | −15.30 pp |
| Q3 2016 | 2016-09-30 | 75.28% | +87.19 pp |
| Q2 2016 | 2016-06-30 | −10.20% | −9.31 pp |
| Q1 2016 | 2016-03-31 | 32.48% | — |
| Q4 2015 | 2015-12-31 | −81.13% | — |
| Q3 2015 | 2015-09-30 | −11.91% | — |
| Q2 2015 | 2015-06-30 | −0.88% | — |
Chemours return on equity trends
Over the last five fiscal years, Chemours's return on equity decreased from 29.16% to −94.03%, a change of −123.19 percentage points. The latest reported quarter, Q2 2026, shows −330.12%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...